Akira Kanno

Title: The Innovative Contributions of Akira Kanno

Akira Kanno is a notable inventor based in Tokyo, Japan. She has made significant strides in the field of protease detection through her innovative patent. Her work has implications for various scientific and medical applications, showcasing her expertise and dedication to advancing technology.

Latest Patents

Akira Kanno holds a patent for an "Activated protease indicator." This invention aims to provide novel approaches capable of detecting activated protease and monitoring protease activation in real-time with high sensitivity in a non-invasive manner. The method involves introducing an indicator in a circular form, comprising the C-half fragment of luciferase (Luc-C) and the N-half fragment of luciferase (Luc-N), linked together through a substrate peptide for a protease. Upon digestion of the substrate peptide by the protease, Luc-N and Luc-C reconstruct active luciferase, allowing for the detection of activated protease by assaying the luminescence signal from the luciferase.

Career Highlights

Throughout her career, Akira Kanno has worked with prestigious institutions, including The University of Tokyo and the Inter-University Research Institute Corporation National Institutes of Natural Sciences. Her contributions to these organizations have been instrumental in advancing research in her field.

Collaborations

Akira Kanno has collaborated with esteemed colleagues, including Yoshio Umezawa and Takeaki Ozawa. These partnerships have further enriched her research and innovation efforts.

Conclusion

Akira Kanno's work in developing the activated protease indicator exemplifies her commitment to innovation in scientific research. Her contributions continue to impact the field positively, paving the way for future advancements.